Surprisingly, the transgenic (TG) mice ubiquitously overexpressing CCDC3 driven by a cytomegalovirus promoter exhibited relieved glucose intolerance, insulin insensitivity, and hepatic steatosis. This evidence concerns the gene CCDC3 and Hepatic steatosis.